Found 34 Enz. Inhib. hit(s) with all data for entry = 6760 
Affinity DataIC50: <100nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: <100nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 110nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 120nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 130nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 140nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 150nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 160nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 160nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 170nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 170nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 190nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 190nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 190nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 200nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 230nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 240nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 250nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 260nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 260nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 300nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 310nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 330nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 340nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 340nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 350nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 360nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 370nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
Affinity DataIC50: 370nMT: 2°CAssay Description:The potencies of the compounds as inhibitors of human hepatic cytochromes P450 of the CYP3A subfamily (particularly CYP3A4) were assessed using well-...More data for this Ligand-Target Pair
